Scholars Central

Conference abstractPublished 3 Aug 2015

Caper: A precious medicinal plant from ancient times

Authors: Eddouks Mohamed, Hebi Morad, Moufid Abderrahmane

Moulay Ismail University, Morocco

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Capparis spinosa Linn. (Capparaceae) was traditionally used for pharmacological purposes and has potential for use in modern cosmetics. This review aims to assess the current available knowledge of Capparis spinosa and its constituents for management of several diseases. Bibliographic investigation was carried out by scrutinizing classical text books and peer reviewed papers, consulting worldwide accepted scientific databases to retrieve available published literature. Only articles on pharmacological and phytochemical studies of Capparis spinosa have been selected. The main pharmacological activities of caper are antidiabetic, antihypertensive, hypolipidemic, antioxidant, antimutagenic, anti-allergic, hepato protective, antibacterial, antiviral, antifungal, immunomodulatory, anti-apoptotic and anti-inflammatory activities. Phytochemicals studies of this plant revealed the existence of many bioactive components such as saccharides and glycosides, flavonoids, alkaloids, terpenoids and volatile oils, fatty acids, vitamin C, vitamin E and steroids. We conclude that Capparis spinosa is beneficial for the treatment of many pathologies supporting then its use in human nutrition and healthcare.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Eddouks Mohamed”
  • BylineArticles whose byline prints “Hebi Morad”
  • BylineArticles whose byline prints “Moufid Abderrahmane”